These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20842631)

  • 21. Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor-mediated suppression of the estrogen sulfotransferase SULT1E1.
    Liu X; Xue R; Yang C; Gu J; Chen S; Zhang S
    J Biol Chem; 2018 Aug; 293(33):12759-12769. PubMed ID: 29929982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting FXR in Cholestasis.
    Keitel V; Dröge C; Häussinger D
    Handb Exp Pharmacol; 2019; 256():299-324. PubMed ID: 31201556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Farnesoid X receptor-induced lysine-specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity.
    Kim YC; Fang S; Byun S; Seok S; Kemper B; Kemper JK
    Hepatology; 2015 Jul; 62(1):220-31. PubMed ID: 25545350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor alpha-controlled metabolic pathways in mice.
    Herrema H; Meissner M; van Dijk TH; Brufau G; Boverhof R; Oosterveer MH; Reijngoud DJ; Müller M; Stellaard F; Groen AK; Kuipers F
    Hepatology; 2010 Mar; 51(3):806-16. PubMed ID: 19998408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity.
    Yamamoto Y; Moore R; Hess HA; Guo GL; Gonzalez FJ; Korach KS; Maronpot RR; Negishi M
    J Biol Chem; 2006 Jun; 281(24):16625-31. PubMed ID: 16606610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of farnesoid X receptor in cholestasis.
    Yuan ZQ; Li KW
    J Dig Dis; 2016 Aug; 17(8):501-509. PubMed ID: 27383832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice.
    Li G; Kong B; Zhu Y; Zhan L; Williams JA; Tawfik O; Kassel KM; Luyendyk JP; Wang L; Guo GL
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):299-305. PubMed ID: 23811326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting FXR in cholestasis: hype or hope.
    Fiorucci S; Distrutti E; Ricci P; Giuliano V; Donini A; Baldelli F
    Expert Opin Ther Targets; 2014 Dec; 18(12):1449-59. PubMed ID: 25200104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear bile acid receptor FXR in the hepatic regeneration.
    Chen WD; Wang YD; Meng Z; Zhang L; Huang W
    Biochim Biophys Acta; 2011 Aug; 1812(8):888-92. PubMed ID: 21167938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling.
    García-Rodríguez JL; Barbier-Torres L; Fernández-Álvarez S; Gutiérrez-de Juan V; Monte MJ; Halilbasic E; Herranz D; Álvarez L; Aspichueta P; Marín JJ; Trauner M; Mato JM; Serrano M; Beraza N; Martínez-Chantar ML
    Hepatology; 2014 May; 59(5):1972-83. PubMed ID: 24338587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of farnesoid X receptor ligand on the metabolism of bile acids in rats with estrogen-induced intrahepatic cholestasis of pregnancy].
    Zou SL; Liu J; Lan Y; Cheng H; Gan XL
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):383-6. PubMed ID: 18510855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Farnesoid X receptor: A "homeostat" for hepatic nutrient metabolism.
    Massafra V; van Mil SWC
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):45-59. PubMed ID: 28986309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited effects of bile acids and small heterodimer partner on hepatitis B virus biosynthesis in vivo.
    Reese VC; Moore DD; McLachlan A
    J Virol; 2012 Mar; 86(5):2760-8. PubMed ID: 22171277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts.
    Fickert P; Fuchsbichler A; Moustafa T; Wagner M; Zollner G; Halilbasic E; Stöger U; Arrese M; Pizarro M; Solís N; Carrasco G; Caligiuri A; Sombetzki M; Reisinger E; Tsybrovskyy O; Zatloukal K; Denk H; Jaeschke H; Pinzani M; Trauner M
    Am J Pathol; 2009 Dec; 175(6):2392-405. PubMed ID: 19910507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of the nuclear receptors FXR, PXR and CAR in normal and cholestatic placenta.
    Geenes VL; Dixon PH; Chambers J; Raguz S; Marin JJ; Bhakoo KK; Williamson C
    Placenta; 2011 Jul; 32(7):535-7. PubMed ID: 21596433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Farnesoid X receptor modulators (2011 - 2014): a patent review.
    Sepe V; Distrutti E; Fiorucci S; Zampella A
    Expert Opin Ther Pat; 2015; 25(8):885-96. PubMed ID: 26183029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease.
    Gadaleta RM; van Mil SW; Oldenburg B; Siersema PD; Klomp LW; van Erpecum KJ
    Biochim Biophys Acta; 2010 Jul; 1801(7):683-92. PubMed ID: 20399894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders.
    Molinaro A; Marschall HU
    Biochem Soc Trans; 2022 Feb; 50(1):361-373. PubMed ID: 35191955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner.
    Del Bas JM; Ricketts ML; Vaqué M; Sala E; Quesada H; Ardevol A; Salvadó MJ; Blay M; Arola L; Moore DD; Pujadas G; Fernandez-Larrea J; Bladé C
    Mol Nutr Food Res; 2009 Jul; 53(7):805-14. PubMed ID: 19496086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Farnesoid X receptor activation mediates head-to-tail chromatin looping in the Nr0b2 gene encoding small heterodimer partner.
    Li G; Thomas AM; Hart SN; Zhong X; Wu D; Guo GL
    Mol Endocrinol; 2010 Jul; 24(7):1404-12. PubMed ID: 20444884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.